Skip to main content

INGALLS & SNYDER LLC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1041885 NEW YORK, NY

Position in HRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,908
-$4,224 QoQ
Shares Held
11,415
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#126
of 160 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

INGALLS & SNYDER LLC holds $733,965,925 across 13 Biotechnology names. HRTX ranks #13 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HRTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,908 11,415
2026-03-31 $9,132 11,415
2025-12-31 $14,839 11,415
2025-09-30 $14,382 11,415
2025-06-30 $23,629 11,415
2025-03-31 $25,113 11,415
2024-12-31 $20,524 13,415
2024-09-30 $26,695 13,415
2024-06-30 $46,952 13,415
2024-03-31 $37,159 13,415
2023-12-31 $19,405 11,415
2023-09-30 $11,757 11,415
2023-06-30 $13,241 11,415
2023-03-31 $17,236 11,415
2022-12-31 $28,537 11,415
2022-09-30 $59,565 14,115
2022-06-30 $39,380 14,115